Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ROIV✓SelectedUSD · ROIVGSK vs ROIV performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs ROIV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+72.9%
ROIV return
+267.7%
Excess return
-194.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioROIVExcessAlpha
1D-0.1%-2.3%+2.2%0.0%
7D-1.3%-5.1%+3.8%-1.1%
30D+2.7%+15.2%-12.4%+2.2%
3M+2.7%+6.7%-3.9%+2.4%
6M+3.3%+31.8%-28.5%+2.1%
YTD+6.5%+77.9%-71.5%+4.1%
1Y+10.7%+90.3%-79.6%+8.0%
3Y+64.4%+328.0%-263.7%+57.1%
5Y+46.7%+370.9%-324.2%+35.8%
All+72.9%+267.7%-194.9%+56.4%

Cumulative growth

Daily Returns

Daily percentage return beside ROIV.

Daily Out/Under-Performance

Portfolio return minus ROIV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling